Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Lung abscess and necrotising pneumonia

Respiratory · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Rapid deterioration, sepsis, major haemoptysis, respiratory failure or a rapidly enlarging cavity requires urgent respiratory and microbiology review, immediate stabilisation and prompt source-directed treatment rather than waiting for complete microbiological certainty.

Synopsis

Recognise pulmonary parenchymal necrosis, identify sepsis, haemorrhage and an obstructing lesion early, and coordinate microbiology-led prolonged therapy with drainage or surgery only when source control is genuinely needed. Verify treatment against current antimicrobial, respiratory, radiology and thoracic-surgical guidance.

  • A lung abscess is a localised pus-containing cavity; necrotising pneumonia is more diffuse parenchymal destruction with multiple small cavities and may progress rapidly.
  • Aspiration, poor dentition, impaired consciousness, swallowing dysfunction, an obstructing tumour, immunosuppression and septic emboli are high-yield causes or contributors.
  • CT with contrast usually characterises cavitation, distinguishes pleural empyema and looks for obstruction, infarction, foreign body or malignancy.
  • Collect blood and good lower-respiratory samples before antibiotics where safe, but never delay sepsis treatment or stabilisation for sampling.
  • Empirical therapy normally covers aerobic and anaerobic oral flora; recent healthcare exposure, influenza, resistant colonisation and immune compromise alter the spectrum.
  • Clinical response is judged over days, but radiological resolution often takes weeks; total antibiotic duration is individualised to response, organism and source control.
  • Persistent fever should trigger a diagnostic reset: inadequate coverage, empyema, blocked drainage, resistant organism, TB, fungus, cancer or non-infective cavitation.
  • Massive haemoptysis, shock, respiratory failure or a tension-like expanding cavity requires immediate escalation and coordinated critical, respiratory, interventional and surgical care.

Key red flags

Fulminant necrotising pneumonia

Rapid hypoxaemia, shock, high inflammatory burden, multilobar consolidation and evolving small cavities, sometimes after influenza. Escalate early because deterioration and organ failure can be abrupt.

Haemorrhage or fistula

Large-volume haemoptysis, falling haemoglobin, new pneumothorax, persistent air leak or expectoration of copious purulent material suggests vascular erosion, rupture or bronchopleural communication.

Investigation priorities

01
Chest radiographFirst step

Confirm consolidation or a cavity, identify an air-fluid level and detect pneumothorax or pleural fluid rapidly.

Management branches

StabiliseSevere necrotising infection

Hypoxaemia, shock, altered mental state, major haemoptysis or rapidly progressive cavitation.

  1. Use an ABCDE approach, controlled oxygen to an individual target, blood cultures and lactate, prompt sepsis antimicrobials and early critical-care review.
  2. Obtain urgent contrast CT when the patient can safely transfer; involve respiratory medicine, microbiology and radiology, and call thoracic surgery or interventional radiology early for haemorrhage, fistula or non-viable lung.
  3. Address pleural sepsis separately with ultrasound-guided drainage and protect the airway if bleeding or reduced consciousness threatens ventilation.
  4. Reassess within hours for organ support, antimicrobial adequacy and evolving source-control needs.

Key medicines

Co-amoxiclavFor a stable adult, a locally approved oral or intravenous regimen selected for severity and renal function; verify current BNF and antimicrobial policy rather than copying a generic dose.Penicillin allergy, hepatic injury, renal adjustment and C. difficile risk. It does not reliably cover MRSA or all resistant hospital Gram-negatives.
Piperacillin with tazobactamIntravenous hospital regimen adjusted for renal function and local extended-infusion policy; confirm current BNF and microbiology advice.Beta-lactam allergy, renal injury, sodium load, cytopenia with prolonged use and ecological harm. Broader is not automatically better.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG250: Pneumonia diagnosis and managementNational pneumonia assessment and antimicrobial-review principles.
  • BTS clinical statement on aspiration pneumoniaUK aspiration spectrum, anaerobic cover, oral care and swallowing context.
  • RCPath UK SMI S2: PneumoniaCurrent UK investigation and specimen framework for pneumonia.
  • RCPath UK SMI B14: Pus and exudatesMicrobiological processing of abscess and other deep-seated pus.
  • BNF: Respiratory infection antibacterial therapyCurrent UK antimicrobial prescribing context.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom